LVEDP is More Reliable Than PAWP Obtained During RHC
When accuracy of pulmonary arterial wedge pressure (PAWP) is in question during right heart catheterization, direct measurement of left ventricular end-diastolic pressure (LVEDP) via left heart catheterization should be performed, as LVEDP is the gold standard for assessing left ventricular filling pressure 1.
The Fundamental Problem with PAWP
While RHC remains the gold standard procedure for diagnosing pulmonary hypertension, PAWP—the measurement obtained during RHC—is not interchangeable with LVEDP in many clinical scenarios 1. The 2025 Chest guidelines explicitly state that "measurement of LVEDP is preferred to dPAP when PAWP cannot be obtained" and emphasize that "ensuring an accurate PAWP is key to evaluating the hemodynamic profile, and if the accuracy of PAWP is in question, left heart catheterization with LVEDP should then be performed" 1.
When PAWP Fails: Specific Clinical Scenarios
PAWP Overestimates LVEDP (PAWP > LVEDP)
This discordance occurs in:
- Atrial fibrillation (associated with 1.75-fold increased odds of PAWP overestimation) 2
- Valvular disease: mitral stenosis, mitral regurgitation, pulmonic stenosis 1
- Rheumatic valve disease (2.2-fold increased odds) 2
- Large left atrial diameter (1.70-fold increased odds) 2
- LA myxoma
- Pulmonary veno-occlusive disease 1
PAWP Underestimates LVEDP (PAWP < LVEDP)
This occurs with:
- Decreased LV compliance 1
- Older age (1.77-fold increased odds of underestimation) 2
- Severe LV hypertrophy 1
- Aortic regurgitation (severe AI causes mitral valve closure and retrograde filling, elevating LVEDP above LA pressure) 1
The Clinical Impact of This Discordance
The consequences of relying on PAWP alone are substantial:
- 53.5% of patients classified as having precapillary pulmonary arterial hypertension based on PAWP ≤15 mmHg actually had LVEDP >15 mmHg, indicating postcapillary disease 3
- In veterans, 46.6% were misclassified when PAWP was used instead of LVEDP 4
- Among patients with PVR >3 Wood units, 40% were reclassified from precapillary to postcapillary PH when LVEDP was measured 4
- Discordance in PVR calculations led to different treatment targets for PH-specific therapy in 22% of ILD patients depending on whether PAWP or LVEDP was used 5
The Statistical Reality
The calibration between PAWP and LVEDP is poor:
- Bland-Altman limits of agreement range from -17.2 to 11.4 mmHg 4
- Mean bias is -2.87 mmHg (PAWP underestimates) 4
- Correlation is only moderate (r = 0.57-0.6) 4, 2
- PAWP provides moderate discrimination (AUC 0.81-0.84) but this is insufficient for definitive classification 3, 4
Critical Pitfall: The ILD Population
In patients with interstitial lung disease, left atrial dysfunction (LAD) occurs in 13.8% and is associated with:
- Lower forced vital capacity (OR 0.956)
- Larger left atrium diameter (OR 3.205)
- PAWP-LVEDP difference >3 mmHg 5
This population requires particularly careful assessment with direct LVEDP measurement.
When to Measure LVEDP Directly
Obtain LVEDP via left heart catheterization when:
- Any of the high-risk clinical features above are present
- PAWP accuracy is uncertain
- Classification between precapillary and postcapillary PH will change management
- Considering pulmonary vasodilator therapy (misclassification leads to dangerous or cost-ineffective treatment) 3
- Enrolling patients in PAH therapeutic trials 3
The Bottom Line
RHC is the correct procedure, but PAWP is not always the correct measurement. The procedure itself (RHC) remains the gold standard for hemodynamic assessment 6, 7, but the specific measurement used to assess left heart filling pressure must be LVEDP when accuracy matters for diagnosis and treatment decisions. The 2025 guidelines are unequivocal: when PAWP accuracy is questioned, proceed to left heart catheterization for direct LVEDP measurement 1.